Bocouture (2×50 units)
What is Bocouture?
Bocouture is a popular choice by patients, under the age of 65, to remove the vertical frown lines in between their eyebrows. Constant frowning is caused by muscular contraction which is difficult for patients to control or prevent by themselves.Buy Bocouture (2×50 units)
How does Bocouture work in the body?
Bocouture helps to relax muscles, by initially blocking the nerve impulses. Bocouture is injected into the muscle area to relax muscles by preventing the constant contraction of them. This effect is reversible and temporary and requires further treatments to maintain its longevity, making it a safe option for patients who choose this medicine.Buy Bocouture (2×50 units)
The desired results enable patients to feel psychologically comfortable with their appearances and emotional wellbeing.Buy Bocouture (2×50 units)
When will results first start to be visible?
Improvement is observed between 2-3 days, however full effects can be seen on day 30.
How long will the result last?
Effects can last for up to 4 months following treatment, hence Bocouture being a temporary reversible solution for many patients.Buy Bocouture (2×50 units)
What side effects are associated with Bocouture?
Muscle weakness and dizziness are possible side effects caused with administration of Bocouture. Patients who operate machinery or are considering driving following treatment should be made aware of this to avoid any possible injury.Buy Bocouture (2×50 units)
Muscle tenderness, itching and swelling are other possible side effects. Side effects common to pre-injection anxiousness include nausea, tinnitus, and temporary vasovagal reactions.
Who should not use Bocouture?
Professional medical advice should be sought first if you experience any of the following:
- bleeding of any type occurs
- you are receiving anticoagulant therapy
- you suffer from amyotrophic lateral sclerosis or other diseases linked to peripheral neuromuscular dysfunction
- you’re muscles show any weakness or atrophy.
There are no reviews yet.